SCHEMBL28901016

SCHEMBL28901016

Cc1[c]c(S(=O)(=O)N2CCCN(C)CCC2)cc([N+](=O)[O-])c1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.46
ALDH1A1 P00352 5/20 0.43
KMT2A Q03164 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
HTT P42858 2/20 0.43
CYP1A2 P05177 2/20 0.43
CYP3A4 P08684 2/20 0.43
CYP2C19 P33261 2/20 0.43
LMNA P02545 2/20 0.42
MCOLN3 Q8TDD5 2/20 0.40
MEN1 O00255 2/20 0.40
RAB9A P51151 1/20 0.40
CRHBP P24387 1/20 0.40
CRHR2 Q13324 1/20 0.40
NPSR1 Q6W5P4 2/20 0.40
HPGD P15428 1/20 0.40
VCAM1 P19320 1/20 0.40
PKM P14618 1/20 0.40
CYP2C9 P11712 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28480715 0.97 KMT2A (0.47) L3MBTL1ALDH1A1KMT2ASMN1; SMN2HTT
SCHEMBL28474493 0.92 HTT (0.47) L3MBTL1ALDH1A1KMT2ASMN1; SMN2HTT
SCHEMBL28486029 0.87 L3MBTL1 (0.43) L3MBTL1ALDH1A1KMT2ASMN1; SMN2HTT
SCHEMBL28473212 0.85 ALDH1A1 (0.46) L3MBTL1ALDH1A1KMT2ASMN1; SMN2HTT
SCHEMBL28478897 0.83 ALDH1A1 (0.40) L3MBTL1ALDH1A1KMT2ASMN1; SMN2HTT
SCHEMBL28482437 0.81 ALDH1A1 (0.43) L3MBTL1ALDH1A1KMT2ASMN1; SMN2HTT
SCHEMBL28474461 0.81 MAPT (0.56) L3MBTL1ALDH1A1KMT2ASMN1; SMN2HTT
SCHEMBL28485993 0.81 LMNA (0.44) L3MBTL1ALDH1A1SMN1; SMN2HTTLMNA
SCHEMBL28480242 0.80 L3MBTL1 (0.49) L3MBTL1ALDH1A1KMT2ASMN1; SMN2HTT
SCHEMBL28485486 0.79 HTT (0.47) L3MBTL1ALDH1A1KMT2ASMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111918864-A Prodrug compounds activated by AKR1C3 and their use to treat hyperproliferative disorders 阿基利斯医疗有限公司 2020-11-10 CN claimed
CN-111918864-B Prodrug compounds activated by AKR1C3 and their use for the treatment of hyperproliferative disorders 阿基利斯医疗有限公司 2024-03-05 CN disclosed
CN-111918864-A Prodrug compounds activated by AKR1C3 and their use to treat hyperproliferative disorders 阿基利斯医疗有限公司 2020-11-10 CN disclosed